Oneness Biotech (Taiwan) Performance
| 4743 Stock | TWD 107.00 0.50 0.47% |
The company holds a Beta of 0.0194, which implies not very significant fluctuations relative to the market. As returns on the market increase, Oneness Biotech's returns are expected to increase less than the market. However, during the bear market, the loss of holding Oneness Biotech is expected to be smaller as well. At this point, Oneness Biotech has a negative expected return of -0.59%. Please make sure to check Oneness Biotech's coefficient of variation, jensen alpha, and the relationship between the mean deviation and standard deviation , to decide if Oneness Biotech performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Oneness Biotech Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors. ...more
| Begin Period Cash Flow | 217.6 M | |
| Total Cashflows From Investing Activities | 59.5 M | |
| Free Cash Flow | -389.2 M |
Oneness |
Oneness Biotech Relative Risk vs. Return Landscape
If you would invest 15,800 in Oneness Biotech Co on August 29, 2024 and sell it today you would lose (5,100) from holding Oneness Biotech Co or give up 32.28% of portfolio value over 90 days. Oneness Biotech Co is generating negative expected returns and assumes 2.3825% volatility on return distribution over the 90 days horizon. Simply put, 21% of stocks are less volatile than Oneness, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Oneness Biotech Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Oneness Biotech's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Oneness Biotech Co, and traders can use it to determine the average amount a Oneness Biotech's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.2471
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 4743 |
Estimated Market Risk
| 2.38 actual daily | 21 79% of assets are more volatile |
Expected Return
| -0.59 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.25 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Oneness Biotech is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Oneness Biotech by adding Oneness Biotech to a well-diversified portfolio.
Oneness Biotech Fundamentals Growth
Oneness Stock prices reflect investors' perceptions of the future prospects and financial health of Oneness Biotech, and Oneness Biotech fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Oneness Stock performance.
| Return On Equity | 0.0788 | |||
| Return On Asset | -0.0068 | |||
| Profit Margin | 1.06 % | |||
| Operating Margin | (0.16) % | |||
| Current Valuation | 92.26 B | |||
| Shares Outstanding | 387.86 M | |||
| Price To Book | 6.54 X | |||
| Price To Sales | 88.17 X | |||
| Revenue | 65.77 M | |||
| EBITDA | (193.72 M) | |||
| Book Value Per Share | 39.63 X | |||
| Cash Flow From Operations | (288.89 M) | |||
| Earnings Per Share | 2.79 X | |||
| Total Asset | 15.73 B | |||
About Oneness Biotech Performance
Evaluating Oneness Biotech's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Oneness Biotech has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Oneness Biotech has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about Oneness Biotech performance evaluation
Checking the ongoing alerts about Oneness Biotech for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Oneness Biotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Oneness Biotech generated a negative expected return over the last 90 days | |
| The company reported the revenue of 65.77 M. Net Loss for the year was (403.3 M) with profit before overhead, payroll, taxes, and interest of 45.04 M. | |
| Oneness Biotech generates negative cash flow from operations | |
| About 31.0% of the company shares are owned by insiders or employees |
- Analyzing Oneness Biotech's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Oneness Biotech's stock is overvalued or undervalued compared to its peers.
- Examining Oneness Biotech's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Oneness Biotech's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Oneness Biotech's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Oneness Biotech's stock. These opinions can provide insight into Oneness Biotech's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Oneness Stock Analysis
When running Oneness Biotech's price analysis, check to measure Oneness Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oneness Biotech is operating at the current time. Most of Oneness Biotech's value examination focuses on studying past and present price action to predict the probability of Oneness Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oneness Biotech's price. Additionally, you may evaluate how the addition of Oneness Biotech to your portfolios can decrease your overall portfolio volatility.